2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$1.89+$0.01 (+0.59%)
Price as of Aug 03, 2026 10:39 AM EDT- $648.9MMarket Cap
- 74.07%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$1.89+$0.01 (+0.59%)
ALLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.88 | ||
Change | -$0.09 (-4.57%) | ||
Open | $1.97 | ||
High | $2.00 | ||
Low | $1.86 | ||
Previous Close | $1.97 | ||
Volume | 5,521,843 | ||
30-Day Average Volume | 7,895,580 | ||
1-Week Change | 8.05% | ||
1-Month Change | -9.62% | ||
1-Year Change | 74.07% | ||
3-Year Change | -62.10% | ||
5-Year Change | -91.44% | ||
Fundamentals | |||
Shares Outstanding | 345.2M | ||
Total Assets | $396.0M | ||
Market Cap | $648.9M | ||
Enterprise Value | $618.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$42.6M | ||
Free Cash Flow | -$12.9M | ||
EBIT | -$42.6M | ||
EBITDA | -$39.7M | ||
Net Working Capital | $245.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -10 | ||
PEG | 2 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue